nodes	percent_of_prediction	percent_of_DWPC	metapath
Tazarotene—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.138	0.213	CbGbCtD
Tazarotene—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.11	0.17	CbGbCtD
Tazarotene—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0995	0.154	CbGbCtD
Tazarotene—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0919	0.142	CbGbCtD
Tazarotene—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0887	0.137	CbGbCtD
Tazarotene—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0723	0.112	CbGbCtD
Tazarotene—CYP2C8—Losartan—type 2 diabetes mellitus	0.0466	0.0721	CbGbCtD
Tazarotene—Hypertriglyceridaemia—Linagliptin—type 2 diabetes mellitus	0.00691	0.0401	CcSEcCtD
Tazarotene—Blood triglycerides increased—Linagliptin—type 2 diabetes mellitus	0.00605	0.0351	CcSEcCtD
Tazarotene—Localised oedema—Irbesartan—type 2 diabetes mellitus	0.00574	0.0333	CcSEcCtD
Tazarotene—Hypertriglyceridaemia—Rosiglitazone—type 2 diabetes mellitus	0.00529	0.0307	CcSEcCtD
Tazarotene—Localized exfoliation—Losartan—type 2 diabetes mellitus	0.00507	0.0294	CcSEcCtD
Tazarotene—Blood triglycerides increased—Rosiglitazone—type 2 diabetes mellitus	0.00464	0.0269	CcSEcCtD
Tazarotene—Skin exfoliation—Linagliptin—type 2 diabetes mellitus	0.00379	0.022	CcSEcCtD
Tazarotene—Burning sensation—Bromocriptine—type 2 diabetes mellitus	0.00322	0.0187	CcSEcCtD
Tazarotene—Hypertriglyceridaemia—Gliclazide—type 2 diabetes mellitus	0.0032	0.0186	CcSEcCtD
Tazarotene—Blood triglycerides increased—Gliclazide—type 2 diabetes mellitus	0.0028	0.0163	CcSEcCtD
Tazarotene—Photosensitivity reaction—Tolbutamide—type 2 diabetes mellitus	0.00252	0.0146	CcSEcCtD
Tazarotene—Photosensitivity reaction—Tolazamide—type 2 diabetes mellitus	0.0023	0.0133	CcSEcCtD
Tazarotene—Photosensitivity reaction—Chlorpropamide—type 2 diabetes mellitus	0.0023	0.0133	CcSEcCtD
Tazarotene—Eczema—Glipizide—type 2 diabetes mellitus	0.00215	0.0125	CcSEcCtD
Tazarotene—Eczema—Sitagliptin—type 2 diabetes mellitus	0.002	0.0116	CcSEcCtD
Tazarotene—Acne—Orlistat—type 2 diabetes mellitus	0.00198	0.0115	CcSEcCtD
Tazarotene—Erythema—Tolbutamide—type 2 diabetes mellitus	0.00193	0.0112	CcSEcCtD
Tazarotene—Dermatitis bullous—Glimepiride—type 2 diabetes mellitus	0.00188	0.0109	CcSEcCtD
Tazarotene—Oedema peripheral—Nateglinide—type 2 diabetes mellitus	0.00184	0.0107	CcSEcCtD
Tazarotene—Erythema—Tolazamide—type 2 diabetes mellitus	0.00175	0.0102	CcSEcCtD
Tazarotene—Stinging—Losartan—type 2 diabetes mellitus	0.00169	0.00978	CcSEcCtD
Tazarotene—Burning sensation—Ramipril—type 2 diabetes mellitus	0.00169	0.00978	CcSEcCtD
Tazarotene—Erythema—Acarbose—type 2 diabetes mellitus	0.00168	0.00977	CcSEcCtD
Tazarotene—Oedema peripheral—Repaglinide—type 2 diabetes mellitus	0.00159	0.00923	CcSEcCtD
Tazarotene—Dermatitis bullous—Glyburide—type 2 diabetes mellitus	0.00155	0.00902	CcSEcCtD
Tazarotene—Photosensitivity reaction—Glipizide—type 2 diabetes mellitus	0.00152	0.00884	CcSEcCtD
Tazarotene—Oedema peripheral—Rosiglitazone—type 2 diabetes mellitus	0.0015	0.00872	CcSEcCtD
Tazarotene—Eczema—Gliclazide—type 2 diabetes mellitus	0.00148	0.00862	CcSEcCtD
Tazarotene—Discomfort—Tolazamide—type 2 diabetes mellitus	0.00147	0.00856	CcSEcCtD
Tazarotene—Photosensitivity reaction—Glimepiride—type 2 diabetes mellitus	0.00142	0.00825	CcSEcCtD
Tazarotene—Erythema—Repaglinide—type 2 diabetes mellitus	0.00141	0.00816	CcSEcCtD
Tazarotene—Swelling—Valsartan—type 2 diabetes mellitus	0.00139	0.00806	CcSEcCtD
Tazarotene—Oedema—Acarbose—type 2 diabetes mellitus	0.00137	0.00798	CcSEcCtD
Tazarotene—Eczema—Orlistat—type 2 diabetes mellitus	0.00135	0.00782	CcSEcCtD
Tazarotene—Skin exfoliation—Losartan—type 2 diabetes mellitus	0.0013	0.00757	CcSEcCtD
Tazarotene—Dermatitis bullous—Valsartan—type 2 diabetes mellitus	0.00128	0.00744	CcSEcCtD
Tazarotene—Dermatitis bullous—Orlistat—type 2 diabetes mellitus	0.00127	0.00735	CcSEcCtD
Tazarotene—Oedema peripheral—Pioglitazone—type 2 diabetes mellitus	0.00126	0.00732	CcSEcCtD
Tazarotene—Oedema peripheral—Sitagliptin—type 2 diabetes mellitus	0.00122	0.0071	CcSEcCtD
Tazarotene—Dry skin—Gliclazide—type 2 diabetes mellitus	0.00122	0.0071	CcSEcCtD
Tazarotene—Swelling—Irbesartan—type 2 diabetes mellitus	0.00119	0.00693	CcSEcCtD
Tazarotene—Photosensitivity reaction—Glyburide—type 2 diabetes mellitus	0.00117	0.0068	CcSEcCtD
Tazarotene—Erythema—Glipizide—type 2 diabetes mellitus	0.00116	0.00675	CcSEcCtD
Tazarotene—Oedema—Repaglinide—type 2 diabetes mellitus	0.00115	0.00666	CcSEcCtD
Tazarotene—Swelling—Losartan—type 2 diabetes mellitus	0.00112	0.00652	CcSEcCtD
Tazarotene—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.00111	0.00646	CcSEcCtD
Tazarotene—Dry skin—Orlistat—type 2 diabetes mellitus	0.00111	0.00644	CcSEcCtD
Tazarotene—Oedema peripheral—Bromocriptine—type 2 diabetes mellitus	0.00111	0.00643	CcSEcCtD
Tazarotene—Rash—Miglitol—type 2 diabetes mellitus	0.0011	0.0064	CcSEcCtD
Tazarotene—Dermatitis—Miglitol—type 2 diabetes mellitus	0.0011	0.00639	CcSEcCtD
Tazarotene—Erythema—Glimepiride—type 2 diabetes mellitus	0.00108	0.0063	CcSEcCtD
Tazarotene—Oedema—Rosiglitazone—type 2 diabetes mellitus	0.00108	0.00629	CcSEcCtD
Tazarotene—Photosensitivity reaction—Gliclazide—type 2 diabetes mellitus	0.00105	0.00611	CcSEcCtD
Tazarotene—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.00101	0.00587	CcSEcCtD
Tazarotene—Pruritus—Tolazamide—type 2 diabetes mellitus	0.00101	0.00587	CcSEcCtD
Tazarotene—Rash—Tolbutamide—type 2 diabetes mellitus	0.000991	0.00575	CcSEcCtD
Tazarotene—Discomfort—Glipizide—type 2 diabetes mellitus	0.000978	0.00568	CcSEcCtD
Tazarotene—Photosensitivity reaction—Valsartan—type 2 diabetes mellitus	0.000967	0.00561	CcSEcCtD
Tazarotene—Oedema—Glipizide—type 2 diabetes mellitus	0.000949	0.00551	CcSEcCtD
Tazarotene—Pruritus—Nateglinide—type 2 diabetes mellitus	0.000937	0.00544	CcSEcCtD
Tazarotene—Discomfort—Pioglitazone—type 2 diabetes mellitus	0.000937	0.00544	CcSEcCtD
Tazarotene—Discomfort—Sitagliptin—type 2 diabetes mellitus	0.00091	0.00528	CcSEcCtD
Tazarotene—Oedema peripheral—Gliclazide—type 2 diabetes mellitus	0.000909	0.00528	CcSEcCtD
Tazarotene—Oedema—Pioglitazone—type 2 diabetes mellitus	0.000909	0.00528	CcSEcCtD
Tazarotene—Dry skin—Losartan—type 2 diabetes mellitus	0.000909	0.00527	CcSEcCtD
Tazarotene—Rash—Tolazamide—type 2 diabetes mellitus	0.000902	0.00523	CcSEcCtD
Tazarotene—Rash—Chlorpropamide—type 2 diabetes mellitus	0.000902	0.00523	CcSEcCtD
Tazarotene—Erythema—Glyburide—type 2 diabetes mellitus	0.000895	0.00519	CcSEcCtD
Tazarotene—Rash—Linagliptin—type 2 diabetes mellitus	0.000892	0.00518	CcSEcCtD
Tazarotene—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000892	0.00517	CcSEcCtD
Tazarotene—Rash—Acarbose—type 2 diabetes mellitus	0.000866	0.00503	CcSEcCtD
Tazarotene—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000866	0.00502	CcSEcCtD
Tazarotene—Haemoglobin—Valsartan—type 2 diabetes mellitus	0.000852	0.00495	CcSEcCtD
Tazarotene—Haemorrhage—Valsartan—type 2 diabetes mellitus	0.000848	0.00492	CcSEcCtD
Tazarotene—Haemoglobin—Orlistat—type 2 diabetes mellitus	0.000842	0.00489	CcSEcCtD
Tazarotene—Haemorrhage—Orlistat—type 2 diabetes mellitus	0.000838	0.00486	CcSEcCtD
Tazarotene—Rash—Nateglinide—type 2 diabetes mellitus	0.000835	0.00485	CcSEcCtD
Tazarotene—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000835	0.00484	CcSEcCtD
Tazarotene—Photosensitivity reaction—Irbesartan—type 2 diabetes mellitus	0.000831	0.00482	CcSEcCtD
Tazarotene—Oedema peripheral—Orlistat—type 2 diabetes mellitus	0.000825	0.00479	CcSEcCtD
Tazarotene—Pain—Glipizide—type 2 diabetes mellitus	0.000811	0.00471	CcSEcCtD
Tazarotene—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000811	0.00471	CcSEcCtD
Tazarotene—Erythema—Gliclazide—type 2 diabetes mellitus	0.000803	0.00466	CcSEcCtD
Tazarotene—Oedema—Bromocriptine—type 2 diabetes mellitus	0.000799	0.00464	CcSEcCtD
Tazarotene—Photosensitivity reaction—Losartan—type 2 diabetes mellitus	0.000782	0.00454	CcSEcCtD
Tazarotene—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000767	0.00445	CcSEcCtD
Tazarotene—Oedema peripheral—Metformin—type 2 diabetes mellitus	0.000761	0.00441	CcSEcCtD
Tazarotene—Pain—Sitagliptin—type 2 diabetes mellitus	0.000755	0.00438	CcSEcCtD
Tazarotene—Oedema—Glyburide—type 2 diabetes mellitus	0.00073	0.00424	CcSEcCtD
Tazarotene—Rash—Repaglinide—type 2 diabetes mellitus	0.000723	0.0042	CcSEcCtD
Tazarotene—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000722	0.00419	CcSEcCtD
Tazarotene—Oedema peripheral—Irbesartan—type 2 diabetes mellitus	0.000718	0.00417	CcSEcCtD
Tazarotene—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000683	0.00397	CcSEcCtD
Tazarotene—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000683	0.00396	CcSEcCtD
Tazarotene—Discomfort—Gliclazide—type 2 diabetes mellitus	0.000676	0.00392	CcSEcCtD
Tazarotene—Erythema—Metformin—type 2 diabetes mellitus	0.000672	0.0039	CcSEcCtD
Tazarotene—Pruritus—Glipizide—type 2 diabetes mellitus	0.000671	0.0039	CcSEcCtD
Tazarotene—Photosensitivity reaction—Ramipril—type 2 diabetes mellitus	0.000671	0.00389	CcSEcCtD
Tazarotene—Erythema—Irbesartan—type 2 diabetes mellitus	0.000634	0.00368	CcSEcCtD
Tazarotene—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000626	0.00364	CcSEcCtD
Tazarotene—Discomfort—Orlistat—type 2 diabetes mellitus	0.000613	0.00356	CcSEcCtD
Tazarotene—Oedema—Valsartan—type 2 diabetes mellitus	0.000602	0.0035	CcSEcCtD
Tazarotene—Rash—Glipizide—type 2 diabetes mellitus	0.000598	0.00347	CcSEcCtD
Tazarotene—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000598	0.00347	CcSEcCtD
Tazarotene—Erythema—Losartan—type 2 diabetes mellitus	0.000597	0.00346	CcSEcCtD
Tazarotene—Oedema—Orlistat—type 2 diabetes mellitus	0.000595	0.00345	CcSEcCtD
Tazarotene—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000579	0.00336	CcSEcCtD
Tazarotene—Discomfort—Metformin—type 2 diabetes mellitus	0.000565	0.00328	CcSEcCtD
Tazarotene—Pain—Gliclazide—type 2 diabetes mellitus	0.000561	0.00325	CcSEcCtD
Tazarotene—Rash—Glimepiride—type 2 diabetes mellitus	0.000558	0.00324	CcSEcCtD
Tazarotene—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000558	0.00324	CcSEcCtD
Tazarotene—Rash—Sitagliptin—type 2 diabetes mellitus	0.000556	0.00323	CcSEcCtD
Tazarotene—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000556	0.00323	CcSEcCtD
Tazarotene—Oedema—Metformin—type 2 diabetes mellitus	0.000549	0.00318	CcSEcCtD
Tazarotene—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000534	0.0031	CcSEcCtD
Tazarotene—Oedema—Irbesartan—type 2 diabetes mellitus	0.000518	0.003	CcSEcCtD
Tazarotene—Pruritus—Glyburide—type 2 diabetes mellitus	0.000517	0.003	CcSEcCtD
Tazarotene—Erythema—Ramipril—type 2 diabetes mellitus	0.000512	0.00297	CcSEcCtD
Tazarotene—Pain—Orlistat—type 2 diabetes mellitus	0.000509	0.00295	CcSEcCtD
Tazarotene—Rash—Bromocriptine—type 2 diabetes mellitus	0.000504	0.00292	CcSEcCtD
Tazarotene—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000503	0.00292	CcSEcCtD
Tazarotene—Discomfort—Losartan—type 2 diabetes mellitus	0.000502	0.00291	CcSEcCtD
Tazarotene—Oedema—Losartan—type 2 diabetes mellitus	0.000487	0.00283	CcSEcCtD
Tazarotene—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000464	0.00269	CcSEcCtD
Tazarotene—Rash—Glyburide—type 2 diabetes mellitus	0.00046	0.00267	CcSEcCtD
Tazarotene—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00046	0.00267	CcSEcCtD
Tazarotene—Pain—Irbesartan—type 2 diabetes mellitus	0.000443	0.00257	CcSEcCtD
Tazarotene—Discomfort—Ramipril—type 2 diabetes mellitus	0.000431	0.0025	CcSEcCtD
Tazarotene—Pruritus—Valsartan—type 2 diabetes mellitus	0.000426	0.00247	CcSEcCtD
Tazarotene—Pruritus—Orlistat—type 2 diabetes mellitus	0.000421	0.00244	CcSEcCtD
Tazarotene—Oedema—Ramipril—type 2 diabetes mellitus	0.000418	0.00242	CcSEcCtD
Tazarotene—Pain—Losartan—type 2 diabetes mellitus	0.000417	0.00242	CcSEcCtD
Tazarotene—Rash—Gliclazide—type 2 diabetes mellitus	0.000413	0.0024	CcSEcCtD
Tazarotene—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000413	0.0024	CcSEcCtD
Tazarotene—Pruritus—Metformin—type 2 diabetes mellitus	0.000388	0.00225	CcSEcCtD
Tazarotene—Rash—Valsartan—type 2 diabetes mellitus	0.00038	0.0022	CcSEcCtD
Tazarotene—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000379	0.0022	CcSEcCtD
Tazarotene—Rash—Orlistat—type 2 diabetes mellitus	0.000375	0.00218	CcSEcCtD
Tazarotene—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000375	0.00218	CcSEcCtD
Tazarotene—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000366	0.00213	CcSEcCtD
Tazarotene—Rash—Metformin—type 2 diabetes mellitus	0.000346	0.00201	CcSEcCtD
Tazarotene—Dermatitis—Metformin—type 2 diabetes mellitus	0.000346	0.00201	CcSEcCtD
Tazarotene—RXRB—islet of Langerhans—type 2 diabetes mellitus	0.000345	0.171	CbGeAlD
Tazarotene—Pruritus—Losartan—type 2 diabetes mellitus	0.000345	0.002	CcSEcCtD
Tazarotene—Rash—Irbesartan—type 2 diabetes mellitus	0.000326	0.00189	CcSEcCtD
Tazarotene—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000326	0.00189	CcSEcCtD
Tazarotene—Rash—Losartan—type 2 diabetes mellitus	0.000307	0.00178	CcSEcCtD
Tazarotene—Dermatitis—Losartan—type 2 diabetes mellitus	0.000307	0.00178	CcSEcCtD
Tazarotene—Pruritus—Ramipril—type 2 diabetes mellitus	0.000296	0.00172	CcSEcCtD
Tazarotene—Rash—Ramipril—type 2 diabetes mellitus	0.000263	0.00153	CcSEcCtD
Tazarotene—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000263	0.00153	CcSEcCtD
Tazarotene—RARG—retina—type 2 diabetes mellitus	0.000262	0.13	CbGeAlD
Tazarotene—RXRB—pancreas—type 2 diabetes mellitus	0.000242	0.12	CbGeAlD
Tazarotene—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—type 2 diabetes mellitus	0.000225	0.00126	CbGpPWpGaD
Tazarotene—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—type 2 diabetes mellitus	0.000222	0.00124	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—CTGF—type 2 diabetes mellitus	0.000215	0.0012	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	0.000211	0.00118	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	0.000207	0.00116	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	0.000207	0.00116	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—CTGF—type 2 diabetes mellitus	0.000206	0.00115	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—CTGF—type 2 diabetes mellitus	0.000206	0.00115	CbGpPWpGaD
Tazarotene—RARA—kidney—type 2 diabetes mellitus	0.000204	0.101	CbGeAlD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	0.000202	0.00113	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	0.000199	0.00111	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NCOA6—type 2 diabetes mellitus	0.000197	0.0011	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—GPX1—type 2 diabetes mellitus	0.000196	0.00109	CbGpPWpGaD
Tazarotene—RARG—adipose tissue—type 2 diabetes mellitus	0.000195	0.0969	CbGeAlD
Tazarotene—RARG—Generic Transcription Pathway—AR—type 2 diabetes mellitus	0.000193	0.00108	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—CYP2E1—type 2 diabetes mellitus	0.000189	0.00106	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A2—type 2 diabetes mellitus	0.000187	0.00104	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	0.000186	0.00104	CbGpPWpGaD
Tazarotene—RARA—adipose tissue—type 2 diabetes mellitus	0.000184	0.0911	CbGeAlD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—type 2 diabetes mellitus	0.000182	0.00102	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	0.000181	0.00101	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	0.000178	0.000996	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	0.000178	0.000996	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	0.000178	0.000996	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—NCOA6—type 2 diabetes mellitus	0.000177	0.000988	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	0.000174	0.00097	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—AR—type 2 diabetes mellitus	0.000173	0.000969	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	0.000172	0.000961	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NCOA6—type 2 diabetes mellitus	0.000169	0.000947	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NCOA6—type 2 diabetes mellitus	0.000169	0.000947	CbGpPWpGaD
Tazarotene—RARB—liver—type 2 diabetes mellitus	0.000168	0.0833	CbGeAlD
Tazarotene—RARA—Generic Transcription Pathway—AR—type 2 diabetes mellitus	0.000166	0.000929	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—AR—type 2 diabetes mellitus	0.000166	0.000929	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	0.000165	0.000922	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—TGFB1—type 2 diabetes mellitus	0.000162	0.000907	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	0.00016	0.000893	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	0.00016	0.000892	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—NR3C1—type 2 diabetes mellitus	0.000156	0.000874	CbGpPWpGaD
Tazarotene—RXRB—liver—type 2 diabetes mellitus	0.000154	0.0766	CbGeAlD
Tazarotene—RARA—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	0.000153	0.000856	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	0.000153	0.000856	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	0.000153	0.000856	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—TNF—type 2 diabetes mellitus	0.000151	0.000847	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	0.000149	0.000834	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	0.000147	0.000819	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	0.000143	0.0008	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—NR3C1—type 2 diabetes mellitus	0.00014	0.000784	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	0.000139	0.000778	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	0.000135	0.000757	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—NR3C1—type 2 diabetes mellitus	0.000134	0.000751	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—NR3C1—type 2 diabetes mellitus	0.000134	0.000751	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—HNF4A—type 2 diabetes mellitus	0.000134	0.000751	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	0.000133	0.000745	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	0.000131	0.000734	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	0.00013	0.000726	CbGpPWpGaD
Tazarotene—RARA—liver—type 2 diabetes mellitus	0.000129	0.0639	CbGeAlD
Tazarotene—RARA—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	0.000126	0.000704	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	0.000126	0.000704	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—MTR—type 2 diabetes mellitus	0.000126	0.000702	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	0.000124	0.000695	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—IL6—type 2 diabetes mellitus	0.000122	0.000683	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	0.000122	0.000682	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—CYP11A1—type 2 diabetes mellitus	0.000122	0.000679	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	0.000121	0.000677	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—HNF4A—type 2 diabetes mellitus	0.00012	0.000673	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	0.00012	0.00067	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	0.000119	0.000666	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—PSMD6—type 2 diabetes mellitus	0.000117	0.000656	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—DNMT1—type 2 diabetes mellitus	0.000117	0.000656	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	0.000117	0.000653	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	0.000116	0.000649	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—HNF4A—type 2 diabetes mellitus	0.000115	0.000645	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—HNF4A—type 2 diabetes mellitus	0.000115	0.000645	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—CTGF—type 2 diabetes mellitus	0.000115	0.000644	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—PTGS2—type 2 diabetes mellitus	0.000115	0.000644	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PTGDS—type 2 diabetes mellitus	0.000114	0.000636	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	0.000111	0.000622	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	0.000109	0.00061	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	0.000109	0.000607	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—GPD2—type 2 diabetes mellitus	0.000108	0.000603	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—PSMD6—type 2 diabetes mellitus	0.000105	0.000588	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—DNMT1—type 2 diabetes mellitus	0.000105	0.000588	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	0.000104	0.000582	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	0.000104	0.000582	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—CTGF—type 2 diabetes mellitus	0.000103	0.000578	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—PSMD6—type 2 diabetes mellitus	0.000101	0.000564	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—PSMD6—type 2 diabetes mellitus	0.000101	0.000564	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—DNMT1—type 2 diabetes mellitus	0.000101	0.000564	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—DNMT1—type 2 diabetes mellitus	0.000101	0.000564	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—CYP2E1—type 2 diabetes mellitus	0.0001	0.000561	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NOTCH2—type 2 diabetes mellitus	9.98e-05	0.000558	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—CYP1A2—type 2 diabetes mellitus	9.92e-05	0.000555	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—CTGF—type 2 diabetes mellitus	9.91e-05	0.000554	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—CTGF—type 2 diabetes mellitus	9.91e-05	0.000554	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	9.9e-05	0.000553	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	9.78e-05	0.000547	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	9.78e-05	0.000547	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—CYP3A4—type 2 diabetes mellitus	9.68e-05	0.000541	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—CYP3A4—type 2 diabetes mellitus	9.54e-05	0.000533	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	9.38e-05	0.000524	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	9.38e-05	0.000524	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—AR—type 2 diabetes mellitus	9.31e-05	0.00052	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—NOTCH2—type 2 diabetes mellitus	8.95e-05	0.0005	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	8.64e-05	0.000483	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NOTCH2—type 2 diabetes mellitus	8.58e-05	0.00048	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NOTCH2—type 2 diabetes mellitus	8.58e-05	0.00048	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—CDKN2B—type 2 diabetes mellitus	8.58e-05	0.000479	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—SIRT1—type 2 diabetes mellitus	8.49e-05	0.000474	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	8.39e-05	0.000469	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—AR—type 2 diabetes mellitus	8.35e-05	0.000467	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	8.29e-05	0.000463	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	8.18e-05	0.000457	CbGpPWpGaD
Tazarotene—CYP2C8—kidney—type 2 diabetes mellitus	8.07e-05	0.0401	CbGeAlD
Tazarotene—RARA—Gene Expression—AR—type 2 diabetes mellitus	8e-05	0.000447	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—AR—type 2 diabetes mellitus	8e-05	0.000447	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	7.8e-05	0.000436	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	7.8e-05	0.000436	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	7.8e-05	0.000436	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—CDKN2B—type 2 diabetes mellitus	7.69e-05	0.00043	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—SIRT1—type 2 diabetes mellitus	7.61e-05	0.000425	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GSTM1—type 2 diabetes mellitus	7.6e-05	0.000425	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NR3C1—type 2 diabetes mellitus	7.53e-05	0.000421	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	7.5e-05	0.000419	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—PPP2CA—type 2 diabetes mellitus	7.49e-05	0.000419	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—CDKN2B—type 2 diabetes mellitus	7.38e-05	0.000412	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—CDKN2B—type 2 diabetes mellitus	7.38e-05	0.000412	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—SIRT1—type 2 diabetes mellitus	7.3e-05	0.000408	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—SIRT1—type 2 diabetes mellitus	7.3e-05	0.000408	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	7.07e-05	0.000395	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—PPARA—type 2 diabetes mellitus	7.05e-05	0.000394	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	6.95e-05	0.000389	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—NR3C1—type 2 diabetes mellitus	6.75e-05	0.000377	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—PPP2CA—type 2 diabetes mellitus	6.72e-05	0.000376	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NR3C1—type 2 diabetes mellitus	6.47e-05	0.000362	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NR3C1—type 2 diabetes mellitus	6.47e-05	0.000362	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—PPP2CA—type 2 diabetes mellitus	6.44e-05	0.00036	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—PPP2CA—type 2 diabetes mellitus	6.44e-05	0.00036	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—PPARA—type 2 diabetes mellitus	6.33e-05	0.000354	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—PPARA—type 2 diabetes mellitus	6.07e-05	0.000339	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—PPARA—type 2 diabetes mellitus	6.07e-05	0.000339	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	5.91e-05	0.00033	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	5.91e-05	0.00033	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—PPARG—type 2 diabetes mellitus	5.83e-05	0.000326	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—BHMT—type 2 diabetes mellitus	5.8e-05	0.000324	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—SERPINE1—type 2 diabetes mellitus	5.25e-05	0.000294	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—PPARG—type 2 diabetes mellitus	5.23e-05	0.000292	CbGpPWpGaD
Tazarotene—CYP2C8—liver—type 2 diabetes mellitus	5.1e-05	0.0253	CbGeAlD
Tazarotene—CYP2C8—Metabolism—PTGDS—type 2 diabetes mellitus	5.07e-05	0.000283	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—AANAT—type 2 diabetes mellitus	5.07e-05	0.000283	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—PPARG—type 2 diabetes mellitus	5.01e-05	0.00028	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—PPARG—type 2 diabetes mellitus	5.01e-05	0.00028	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	4.82e-05	0.000269	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GPD2—type 2 diabetes mellitus	4.81e-05	0.000269	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CDO1—type 2 diabetes mellitus	4.81e-05	0.000269	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—SERPINE1—type 2 diabetes mellitus	4.71e-05	0.000263	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	4.7e-05	0.000263	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	4.67e-05	0.000261	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—AK1—type 2 diabetes mellitus	4.58e-05	0.000256	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	4.53e-05	0.000253	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—SERPINE1—type 2 diabetes mellitus	4.52e-05	0.000252	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—SERPINE1—type 2 diabetes mellitus	4.52e-05	0.000252	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—MAT1A—type 2 diabetes mellitus	4.23e-05	0.000236	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SLC5A4—type 2 diabetes mellitus	4.23e-05	0.000236	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	4.21e-05	0.000235	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	4.13e-05	0.000231	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	4.1e-05	0.000229	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—HBA2—type 2 diabetes mellitus	4.09e-05	0.000228	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—G6PC—type 2 diabetes mellitus	4.09e-05	0.000228	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ENPP1—type 2 diabetes mellitus	4.09e-05	0.000228	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PPP1R3C—type 2 diabetes mellitus	4.09e-05	0.000228	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ND1—type 2 diabetes mellitus	4.09e-05	0.000228	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GCGR—type 2 diabetes mellitus	3.96e-05	0.000221	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	3.81e-05	0.000213	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CYTB—type 2 diabetes mellitus	3.74e-05	0.000209	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—OXCT1—type 2 diabetes mellitus	3.74e-05	0.000209	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SRD5A1—type 2 diabetes mellitus	3.64e-05	0.000204	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ACACA—type 2 diabetes mellitus	3.47e-05	0.000194	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—STAR—type 2 diabetes mellitus	3.47e-05	0.000194	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—HSD17B3—type 2 diabetes mellitus	3.47e-05	0.000194	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ABCC8—type 2 diabetes mellitus	3.33e-05	0.000186	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CBS—type 2 diabetes mellitus	3.33e-05	0.000186	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SLC5A2—type 2 diabetes mellitus	3.21e-05	0.000179	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—COX2—type 2 diabetes mellitus	3.21e-05	0.000179	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—NCOA6—type 2 diabetes mellitus	3.15e-05	0.000176	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	3.15e-05	0.000176	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—UCP3—type 2 diabetes mellitus	3.1e-05	0.000173	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—UCP2—type 2 diabetes mellitus	3.1e-05	0.000173	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—HSD11B1—type 2 diabetes mellitus	3.1e-05	0.000173	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	3e-05	0.000168	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PCK1—type 2 diabetes mellitus	2.91e-05	0.000163	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	2.87e-05	0.00016	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	2.8e-05	0.000156	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—HK1—type 2 diabetes mellitus	2.73e-05	0.000152	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	2.72e-05	0.000152	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—KCNJ11—type 2 diabetes mellitus	2.63e-05	0.000147	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—HSD3B2—type 2 diabetes mellitus	2.63e-05	0.000147	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GCKR—type 2 diabetes mellitus	2.63e-05	0.000147	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—LPA—type 2 diabetes mellitus	2.63e-05	0.000147	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	2.53e-05	0.000142	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ALDOB—type 2 diabetes mellitus	2.52e-05	0.000141	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2.45e-05	0.000137	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	2.4e-05	0.000134	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	2.37e-05	0.000133	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GLP1R—type 2 diabetes mellitus	2.35e-05	0.000131	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—AKT1—type 2 diabetes mellitus	2.31e-05	0.000129	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SLC2A2—type 2 diabetes mellitus	2.19e-05	0.000122	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—MTR—type 2 diabetes mellitus	2.15e-05	0.00012	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CPT1A—type 2 diabetes mellitus	2.15e-05	0.00012	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—NAMPT—type 2 diabetes mellitus	2.1e-05	0.000118	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	2.09e-05	0.000117	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—LIPC—type 2 diabetes mellitus	2.09e-05	0.000117	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—HBA1—type 2 diabetes mellitus	2.09e-05	0.000117	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GCK—type 2 diabetes mellitus	2.09e-05	0.000117	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CYP11A1—type 2 diabetes mellitus	2.08e-05	0.000116	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—AKT1—type 2 diabetes mellitus	2.07e-05	0.000116	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SLC9A1—type 2 diabetes mellitus	2.04e-05	0.000114	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CETP—type 2 diabetes mellitus	2.02e-05	0.000113	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—AKT1—type 2 diabetes mellitus	1.98e-05	0.000111	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—AKT1—type 2 diabetes mellitus	1.98e-05	0.000111	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.88e-05	0.000105	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PSMD6—type 2 diabetes mellitus	1.88e-05	0.000105	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SREBF1—type 2 diabetes mellitus	1.88e-05	0.000105	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SNAP25—type 2 diabetes mellitus	1.88e-05	0.000105	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CTGF—type 2 diabetes mellitus	1.84e-05	0.000103	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—HMGCR—type 2 diabetes mellitus	1.83e-05	0.000102	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.8e-05	0.000101	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ADRA2A—type 2 diabetes mellitus	1.79e-05	9.98e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CYP2E1—type 2 diabetes mellitus	1.72e-05	9.59e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SLC2A1—type 2 diabetes mellitus	1.7e-05	9.48e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CYP1A2—type 2 diabetes mellitus	1.7e-05	9.48e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CYP3A4—type 2 diabetes mellitus	1.65e-05	9.25e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.65e-05	9.2e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	1.63e-05	9.09e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	1.63e-05	9.09e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.4e-05	7.84e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	1.4e-05	7.84e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	1.4e-05	7.8e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	1.38e-05	7.7e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	1.34e-05	7.47e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	1.3e-05	7.27e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	1.28e-05	7.13e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	1.25e-05	6.98e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	1.25e-05	6.96e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	1.21e-05	6.78e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	1.2e-05	6.69e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	1.15e-05	6.42e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	1.13e-05	6.3e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	1.09e-05	6.1e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	1.07e-05	6e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	1.07e-05	5.98e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	1.06e-05	5.91e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	9.32e-06	5.21e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	9.14e-06	5.11e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	8.38e-06	4.68e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	8.02e-06	4.48e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	8.02e-06	4.48e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	7.33e-06	4.1e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	3.68e-06	2.06e-05	CbGpPWpGaD
